HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

surfacen

an exogenous natural lung surfactant with antimicrobial and antiprotozoal activities

Networked: 2 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Lipids: 114793
- Membrane Lipids: 1591
  - Phospholipids: 11903
    - surfacen: 2
Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Pulmonary Surfactant-Associated Proteins: 23
    - surfacen: 2

Experts

1.	Blanco, Odalys: 1 article (01/2018)
2.	Cruz, Antonio: 1 article (01/2018)
3.	Echaide, Mercedes: 1 article (01/2018)
4.	Lugones, Yuliannis: 1 article (01/2018)
5.	López-Rodríguez, Elena: 1 article (01/2018)
6.	Pérez-Gil, Jesús: 1 article (01/2018)

Related Diseases

1.	Lung Injury 01/01/2018 - "As it occurs with native surfactant, Surfacen is markedly protected from inhibition by pre-exposure to hyaluronic acid, confirming that clinical surfactants can be improved to treat pathologies associated with strongly deactivating contexts, such as those associated with lung injury and inflammation. "
2.	Inflammation (Inflammations) 01/01/2018 - "As it occurs with native surfactant, Surfacen is markedly protected from inhibition by pre-exposure to hyaluronic acid, confirming that clinical surfactants can be improved to treat pathologies associated with strongly deactivating contexts, such as those associated with lung injury and inflammation. "
3.	Lung Diseases (Lung Disease) 10/31/2022 - "rCmPI-II does not affect Surfacen's interface property and, therefore, both can be evaluated for combined use in treating inflammatory lung diseases."

Related Drugs and Biologics

1.	Surface-Active Agents (Surfactants)
2.	Hyaluronic Acid (Hyaluronan)